Stay updated on Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Sign up to get notified when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.

Latest updates to the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page
- Check5 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed from the record history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe history shows a new revision entry (v3.4.2) indicating an update to the study record; a government funding notice and the prior revision note (v3.4.1) were removed.SummaryDifference0.9%

- Check41 days agoChange DetectedA government funding notice banner was added and the page revision updated to v3.4.1, replacing the previous v3.4.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check48 days agoChange DetectedThe study history UI now shows color-coded additions and deletions, and displays revision labels (e.g., Revision: v3.4.0). It also adds a glossary toggle and explanatory notes about how changes are shown.SummaryDifference1%

- Check62 days agoChange DetectedThe Record History shows a new revision v3.3.4 added and the previous v3.3.3 removed; no other study details or core content were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision: v3.3.3 was added to the page footer, and the entries for 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed. This is a UI/metadata update and does not alter trial data or study details.SummaryDifference0.2%

Stay in the know with updates to Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.